Overview
Chemical Watch quoted Steptoe partner Joe Dages in an article titled, "US FDA official charts path ahead for food chemical regulations," which covers the FDA's active agenda to reform the Generally Recognized as Safe (GRAS) process, strengthen post‑market reviews, and begin research into PFAS and microplastic contaminants in the food supply.
Commenting on the implications for industry, Dages urged the FDA to balance transparency objectives with the practical constraints companies and regulators face, particularly given that many historical GRAS determinations involve substances that may no longer be on the market. As Dages noted, "Is there a benefit in requiring a retrospective rule that requires notification of substances determined to be GRAS decades ago but are no longer in the stream of commerce? There are some real questions about the best use of public resources."
Read the full article in Chemical Watch (Subscription Required)
